PCVX - Vaxcyte to Present at Upcoming Investor Conferences | Benzinga

SAN CARLOS, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (NASDAQ:PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced that Company management will participate in fireside chats and host one-on-one meetings at the following investor conferences:

Guggenheim 5^th Annual Inflammation & Immunology Conference
November 6-7, 2023

• Fireside Chat will take place live on Tuesday, November 7 at 11:10AM ET
  

Jefferies London Healthcare Conference
November 14-16, 2023

• Fireside Chat will take place live on Tuesday, November 14 at 8:00AM GMT / 3:00AM ET
  

Evercore ISI 6^th Annual HealthCONx Conference
November 28-30, 2023

• Fireside Chat will take place live on Tuesday, November 28 at 8:20AM ET
  

Full story available on Benzinga.com